Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo
- PMID: 11160403
- PMCID: PMC6762223
- DOI: 10.1523/JNEUROSCI.21-04-01327.2001
Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo
Abstract
The Alzheimer's disease-related beta-amyloid precursor protein (beta-APP) is metabolized to a number of potentially amyloidogenic peptides that are believed to be pathogenic. Application of relatively low concentrations of the soluble forms of these peptides has previously been shown to block high-frequency stimulation-induced long-term potentiation (LTP) of glutamatergic transmission in the hippocampus. The present experiments examined how these peptides affect low-frequency stimulation-induced long-term depression (LTD) and the reversal of LTP (depotentiation). We discovered that beta-amyloid peptide (Abeta1-42) and the Abeta-containing C -terminus of beta-APP (CT) facilitate the induction of LTD in the CA1 area of the intact rat hippocampus. The LTD was frequency- and NMDA receptor-dependent. Thus, although low-frequency stimulation alone was ineffective, after intracerebroventricular injection of Abeta1-42, it induced an LTD that was blocked by d-(-)-2-amino-5-phosphonopentanoic acid. Furthermore, an NMDA receptor-dependent depotentiation was induced in a time-dependent manner, being evoked by injection of CT 10 min, but not 1 hr, after LTP induction. These use- and time-dependent effects of the amyloidogenic peptides on synaptic plasticity promote long-lasting reductions in synaptic strength and oppose activity-dependent strengthening of transmission in the hippocampus. This will result in a profound disruption of information processing dependent on hippocampal synaptic plasticity.
Figures




Similar articles
-
Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments.Neuroreport. 1997 Oct 20;8(15):3213-7. doi: 10.1097/00001756-199710200-00006. Neuroreport. 1997. PMID: 9351645
-
Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3.Neuroscience. 2013 Dec 3;253:435-43. doi: 10.1016/j.neuroscience.2013.08.054. Epub 2013 Sep 5. Neuroscience. 2013. PMID: 24012839
-
NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.Brain Res. 2003 Apr 11;968(2):263-72. doi: 10.1016/s0006-8993(03)02269-8. Brain Res. 2003. PMID: 12663096
-
Alzheimer's disease amyloid beta-protein and synaptic function.Neuromolecular Med. 2010 Mar;12(1):13-26. doi: 10.1007/s12017-009-8091-0. Epub 2009 Sep 16. Neuromolecular Med. 2010. PMID: 19757208 Review.
-
Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease?Neural Regen Res. 2023 Jun;18(6):1213-1219. doi: 10.4103/1673-5374.360166. Neural Regen Res. 2023. PMID: 36453396 Free PMC article. Review.
Cited by
-
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338. doi: 10.1101/cshperspect.a006338. Cold Spring Harb Perspect Med. 2012. PMID: 22762015 Free PMC article. Review.
-
Early impairment of long-term depression in the perirhinal cortex of a mouse model of Alzheimer's disease.Rejuvenation Res. 2012 Apr;15(2):231-4. doi: 10.1089/rej.2011.1311. Rejuvenation Res. 2012. PMID: 22533438 Free PMC article.
-
Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.J Biol Chem. 2010 Nov 26;285(48):37415-26. doi: 10.1074/jbc.M110.186411. Epub 2010 Sep 23. J Biol Chem. 2010. PMID: 20864542 Free PMC article.
-
AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.Neuron. 2006 Dec 7;52(5):831-43. doi: 10.1016/j.neuron.2006.10.035. Neuron. 2006. PMID: 17145504 Free PMC article.
-
Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease.Drugs Aging. 2004;21(10):621-30. doi: 10.2165/00002512-200421100-00001. Drugs Aging. 2004. PMID: 15287821 Review.
References
-
- Arriagada PV, Growdon JH, Hedleywhyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42:631–639. - PubMed
-
- Baekelandt V, Moechars D, Laenen I, Lorent K, Van Leuven F. Disturbance of the glutamatergic system in mice transgenic for the amyloid precursor protein. Alzheimers Rep. 1999;2:359–368.
-
- Bear M, Abraham W. Long-term depression in the hippocampus. Annu Rev Neurosci. 1996;19:437–462. - PubMed
-
- Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci. 1999;2:271–276. - PubMed
-
- Chen QS, Kagan BL, Hirakura Y, Xie CW. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res. 2000;60:65–72. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous